APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Analysis and Forecast 2026-2032

Report ID 173993950219 December 2025190 pages

Choose your research edition.

Industry ResearchGamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 include Takeda, Jiangsu Hengrui Medicine Co Ltd, Jiangsu Nhwa Pharmaceutical Corp Ltd, Pfizer Inc, Primex Pharmaceuticals Oy and Paion AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2, also provides the revenue of main regions and countries. Of the upcoming market potential for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 revenue, projected growth trends, production technology, application and end-user industry.

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Company

Takeda

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Nhwa Pharmaceutical Corp Ltd

Pfizer Inc

Primex Pharmaceuticals Oy

Paion AG

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Type

EL-001

Midazolam Hydrochloride

LASSBio-786

LASSBio-785

Others

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Application

Insomnia

General Anesthetic Effect

Hypertension

Others

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. EL-001 Major Player Table 3. Midazolam Hydrochloride Major Player Table 4. LASSBio-786 Major Player Table 5. LASSBio-785 Major Player Table 6. Others Major Player Table 7. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Insomnia Major Player Table 9. General Anesthetic Effect Major Player Table 10. Hypertension Major Player Table 11. Others Major Player Table 12. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Trends Table 13. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Drivers Table 14. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Opportunities and Challenges Table 15. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Restraints Table 16. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Region (2021-2026) Table 19. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Region (2027-2032) Table 21. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Players (2021-2026) Table 23. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Key Players Headquarters & Area Served Table 25. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players, Product Type & Application Table 26. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Type (2021-2026) Table 33. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Type (2027-2032) Table 34. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Application (2021-2026) Table 38. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Application (2027-2032) Table 39. Takeda Company Information Table 40. Takeda Business Overview Table 41. Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 43. Takeda Recent Development Table 44. Jiangsu Hengrui Medicine Co Ltd Company Information Table 45. Jiangsu Hengrui Medicine Co Ltd Business Overview Table 46. Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 48. Jiangsu Hengrui Medicine Co Ltd Recent Development Table 49. Jiangsu Nhwa Pharmaceutical Corp Ltd Company Information Table 50. Jiangsu Nhwa Pharmaceutical Corp Ltd Business Overview Table 51. Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 53. Jiangsu Nhwa Pharmaceutical Corp Ltd Recent Development Table 54. Pfizer Inc Company Information Table 55. Pfizer Inc Business Overview Table 56. Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 58. Pfizer Inc Recent Development Table 59. Primex Pharmaceuticals Oy Company Information Table 60. Primex Pharmaceuticals Oy Business Overview Table 61. Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 63. Primex Pharmaceuticals Oy Recent Development Table 64. Paion AG Company Information Table 65. Paion AG Business Overview Table 66. Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 68. Paion AG Recent Development Table 69. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026) & (US$ Million) Table 70. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032) & (US$ Million) Table 71. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026) & (US$ Million) Table 72. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032) & (US$ Million) Table 73. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021-2026) & (US$ Million) Table 75. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (US$ Million) & (2027-2032) Table 76. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026) & (US$ Million) Table 77. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032) & (US$ Million) Table 78. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026) & (US$ Million) Table 79. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032) & (US$ Million) Table 80. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021-2026) & (US$ Million) Table 82. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (US$ Million) & (2027-2032) Table 83. China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026) & (US$ Million) Table 84. China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032) & (US$ Million) Table 85. China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026) & (US$ Million) Table 86. China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026) & (US$ Million) Table 88. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032) & (US$ Million) Table 89. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026) & (US$ Million) Table 90. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Region (US$ Million) & (2021-2026) Table 93. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Region (US$ Million) & (2027-2032) Table 94. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026) & (US$ Million) Table 95. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032) & (US$ Million) Table 96. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026) & (US$ Million) Table 97. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032) & (US$ Million) Table 98. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021-2026) & (US$ Million) Table 100. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (US$ Million) & (2027-2032) Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Image Figure 2. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Share 2021 VS 2025 VS 2032 Figure 4. EL-001 Image Figure 5. Midazolam Hydrochloride Image Figure 6. LASSBio-786 Image Figure 7. LASSBio-785 Image Figure 8. Others Image Figure 9. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Insomnia Image Figure 12. General Anesthetic Effect Image Figure 13. Hypertension Image Figure 14. Others Image Figure 15. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size (US$ Million) & (2021-2032) Figure 16. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Type (2021-2032) Figure 23. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Application (2021-2032) Figure 26. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Type (2021-2032) Figure 28. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Application (2021-2032) Figure 29. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Country (2021-2032) Figure 30. United States Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Type (2021-2032) Figure 35. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Application (2021-2032) Figure 36. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Country (2021-2032) Figure 37. Germany Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Type (2021-2032) Figure 47. China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Application (2021-2032) Figure 48. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Type (2021-2032) Figure 50. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Application (2021-2032) Figure 51. Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Region (2021-2032) Figure 52. Japan Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Type (2021-2032) Figure 60. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Application (2021-2032) Figure 61. SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Country (2021-2032) Figure 62. Brazil Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • EL-001
  • Midazolam Hydrochloride
  • LASSBio-786
  • LASSBio-785
  • Others
Applications
  • Insomnia
  • General Anesthetic Effect
  • Hypertension
  • Others
Companies covered
  • Takeda
  • Jiangsu Hengrui Medicine Co Ltd
  • Jiangsu Nhwa Pharmaceutical Corp Ltd
  • Pfizer Inc
  • Primex Pharmaceuticals Oy
  • Paion AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Type
  3. 1.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 EL-001
  5. 1.2.3 Midazolam Hydrochloride
  6. 1.2.4 LASSBio-786
  7. 1.2.5 LASSBio-785
  8. 1.2.6 Others
  9. 1.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Application
  10. 1.3.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Insomnia
  12. 1.3.3 General Anesthetic Effect
  13. 1.3.4 Hypertension
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Dynamics
  1. 2.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Trends
  2. 2.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Drivers
  3. 2.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Opportunities and Challenges
  4. 2.4 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Perspective (2021-2032)
  2. 3.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Growth Trends by Region
  3. 3.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region (2021-2026)
  5. 3.2.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Players
  2. 4.1.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Players (2021-2026)
  3. 4.1.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Key Players Headquarters & Area Served
  7. 4.4 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players, Product Type & Application
  8. 4.5 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market CR5 and HHI
  11. 4.6.3 2025 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Tier 1, Tier 2, and Tier 3
5 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type
  1. 5.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2032)
  3. 5.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Type (2021-2032)
6 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application
  1. 6.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2032)
  3. 6.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Jiangsu Hengrui Medicine Co Ltd
  8. 7.2.1 Jiangsu Hengrui Medicine Co Ltd Company Information
  9. 7.2.2 Jiangsu Hengrui Medicine Co Ltd Business Overview
  10. 7.2.3 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  12. 7.2.5 Jiangsu Hengrui Medicine Co Ltd Recent Developments
  13. 7.3 Jiangsu Nhwa Pharmaceutical Corp Ltd
  14. 7.3.1 Jiangsu Nhwa Pharmaceutical Corp Ltd Company Information
  15. 7.3.2 Jiangsu Nhwa Pharmaceutical Corp Ltd Business Overview
  16. 7.3.3 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  18. 7.3.5 Jiangsu Nhwa Pharmaceutical Corp Ltd Recent Developments
  19. 7.4 Pfizer Inc
  20. 7.4.1 Pfizer Inc Company Information
  21. 7.4.2 Pfizer Inc Business Overview
  22. 7.4.3 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  24. 7.4.5 Pfizer Inc Recent Developments
  25. 7.5 Primex Pharmaceuticals Oy
  26. 7.5.1 Primex Pharmaceuticals Oy Company Information
  27. 7.5.2 Primex Pharmaceuticals Oy Business Overview
  28. 7.5.3 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  30. 7.5.5 Primex Pharmaceuticals Oy Recent Developments
  31. 7.6 Paion AG
  32. 7.6.1 Paion AG Company Information
  33. 7.6.2 Paion AG Business Overview
  34. 7.6.3 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  36. 7.6.5 Paion AG Recent Developments
8 North America
  1. 8.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (2021-2032)
  2. 8.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2032)
  3. 8.2.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026)
  4. 8.2.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032)
  5. 8.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Type (2021-2032)
  6. 8.4 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2032)
  7. 8.4.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026)
  8. 8.4.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032)
  9. 8.5 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Application (2021-2032)
  10. 8.6 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country
  11. 8.6.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021-2026)
  13. 8.6.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (2021-2032)
  2. 9.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032)
  5. 9.3 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032)
  9. 9.5 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country
  11. 9.6.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (2021-2032)
  2. 10.2 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2032)
  3. 10.2.1 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026)
  4. 10.2.2 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032)
  5. 10.3 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Type (2021-2032)
  6. 10.4 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2032)
  7. 10.4.1 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026)
  8. 10.4.2 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032)
  9. 10.5 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (2021-2032)
  2. 11.2 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032)
  5. 11.3 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032)
  9. 11.5 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country
  11. 11.6.1 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (2021-2032)
  2. 12.2 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country
  11. 12.6.1 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst